Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Artigo em Chinês | WPRIM | ID: wpr-487462

RESUMO

Objective To provide references for the education of intellectual property of TCM universities and colleges.Methods A questionnaire investigation were administered to the graduate students of traditional Chinese medicine from 5 domestic TCM universities and colleges, and data were collected and analyzed, with the addition of Internet information searching. The importance of intellectual property education for graduate students and the status in the end were analyzed.Results Some noticeable problems still exist in the graduate student education on intellectual property, like lack of curriculums, poor after-class practice, less special lectures, and so on.Conclusion In order to tackle these problems, and to make the education of graduate students of traditional Chinese medicine better, the corresponding cultivation mechanisms should be established; the main educational points should be definite; the secure system of laboratory should be improved.

2.
China Pharmacy ; (12): 2221-2224, 2016.
Artigo em Chinês | WPRIM | ID: wpr-504490

RESUMO

OBJECTIVE:To classify the drug properties of Compositae involved in effective patent of TCM extract combina-tion. METHODS:Property,flavor and the meridian tropism of TCM were used as the parameters;by computer analysis software, fuzzy cluster analysis was conducted from Compositae mostly involved in effective patent of TCM extract combination which ap-proved before Jan. 1st in 2015 and kept till May 30th in 2015. RESULTS & CONCLUSIONS:27 ingredients of Compositae were involved with the functions as protecting liver almost. They were classified into 5 categories. The first category included 10 ingredi-ents as Dendranthema morifolium which were cold,bitter to taste,and in the liver and lung meridian,and all of them contained flavonoids compounds;the second category included 3 ingredients as Gnaphalium affine of which flavonoids compounds were main medicinal components;the third category included 5 ingredients as Atractylodes lancea which could protect liver and contained vola-tile oil;the forth category included 4 ingredients as Tussilago farfara which showed anti-inflammatory and anti-tumor effect;the fifth category included 5 ingredients as Erigeron breviscapus which contained ingredients for cardiovascular disease. Those catego-ries were similar not only in property,flavor and the meridian tropism,but also in active ingredients and effects. The researchers should further research TCM of which pharmacologic action are not well understood,by means of make reference to known TCM in the same category,and make preparation to save time and enlarge medicinal resource.

3.
Zhongguo Zhong Yao Za Zhi ; (24): 9-12, 2012.
Artigo em Chinês | WPRIM | ID: wpr-288655

RESUMO

Current patent protection of traditional Chinese medicine (TCM) compounds is far from being satisfactory with increasing research and development achievements. As patent protection of traditional Chinese medicine compounds is closely related with many fields such as research and development of new TCM drugs, industrial development and TCM internationalization, the development of research and harmonious development of TCM compounds and their patent protection is bound to have a far-reaching influence on domestic and even international societies.


Assuntos
Humanos , Química Farmacêutica , Economia , China , Medicamentos de Ervas Chinesas , Química , Economia , Medicina Tradicional Chinesa , Economia , Patentes como Assunto
4.
Zhongguo Zhong Yao Za Zhi ; (24): 2478-2482, 2012.
Artigo em Chinês | WPRIM | ID: wpr-263902

RESUMO

<p><b>OBJECTIVE</b>To discuss the authorized patent of compound traditional Chinese medicines with different efficacy in 2010, in order to provide reference for R&D of relevant compounds and patent protection.</p><p><b>METHOD</b>Literatures for patents of compound traditional Chinese medicines were searched to screen relevant data and create a sample space. The samples were classified by hierarchical cluster procedures and iterative partitioning procedures using "authorized percentage" and "authorized time interval" as variable quantities. The comprehensive results generated by the two clustering methods were used to draw a conclusion.</p><p><b>RESULT</b>The samples were classified into four groups by clustering methods, each has significant difference in authorized patents' number and authorized time interval with others.</p><p><b>CONCLUSION</b>Among compounds showing therapeutic advantage of traditional Chinese medicines, patents with short authorization period and in less number can be given most attention for patent application. Those with longer authorization period and in less number can be given more attention. While those with shorter authorization period and in large number can also be given attention for information guidance for traditional Chinese medicine science and technology and commercialization of patent achievements.</p>


Assuntos
Humanos , Química Farmacêutica , Padrões de Referência , China , Análise por Conglomerados , Tratamento Farmacológico , Medicamentos de Ervas Chinesas , Química , Padrões de Referência , Usos Terapêuticos , Medicina Tradicional Chinesa , Padrões de Referência , Patentes como Assunto
5.
Zhongguo Zhong Yao Za Zhi ; (24): 2472-2477, 2012.
Artigo em Chinês | WPRIM | ID: wpr-263903

RESUMO

<p><b>OBJECTIVE</b>To study current regional development and optimization schemes of patents of traditional Chinese medicine compounds.</p><p><b>METHOD</b>Simple statistics and cluster analysis were adopted for calculating application quantity, maintenance quantity and quantity of scientific research papers related to patents of traditional Chinese medicine compounds in different regions. On that basis, cluster analysis was used for studying current development patents of traditional Chinese medicine compounds in different regions.</p><p><b>RESULT</b>The 34 regions, including Chinese mainland, Hong Kong, Macau and Taiwan, were divided into four groups by cluster analysis according to the difference in quantities of patents and research papers. The first and third region are better, the second region is medium, while the forth region is not ideal.</p><p><b>CONCLUSION</b>Different regions shall adopt suitable development schemes for the development of traditional Chinese medicine compounds according to their actual situations. Reasonable regional alliance is helpful for inter-regional win-win and co-flourishing.</p>


Assuntos
Humanos , Química Farmacêutica , Padrões de Referência , China , Análise por Conglomerados , Tratamento Farmacológico , Medicamentos de Ervas Chinesas , Química , Padrões de Referência , Usos Terapêuticos , Medicina Tradicional Chinesa , Padrões de Referência , Patentes como Assunto
6.
Zhongguo Zhong Yao Za Zhi ; (24): 803-807, 2010.
Artigo em Chinês | WPRIM | ID: wpr-281712

RESUMO

Pharmaceutical standard system which belongs to an important part of national drug policies is an inevitable result of the development of pharmacy. There was a long standing of pharmaceutical standard system in China whose germination could be traced back to Qin and Han dynasties, and it had laid a solid foundation for the establishment and improvement of modern pharmaceutical standard system by continual accumulation from the past dynasties. Since the founding of new China, distinguished achievements had been obtained on pharmaceutical standardization working,and currently it is in a new developing stage. There was a brief description in this paper on the development history of pharmaceutical standard system in China.


Assuntos
Humanos , China , Formas de Dosagem , Padrões de Referência , Educação em Farmácia , História , História do Século XX , História do Século XXI , História Antiga , Preparações Farmacêuticas , História , Padrões de Referência , Assistência Farmacêutica , História , Padrões de Referência , Farmácia , História , Padrões de Referência , Controle de Qualidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA